Last Updated: September 24, 2026

ETHAMOLIN Drug Patent Profile

Name: ETHAMOLIN Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Ethamolin patents expire, and when can generic versions of Ethamolin launch?

Ethamolin is a drug marketed by Qol Medcl and is included in one NDA.

The generic ingredient in ETHAMOLIN is ethanolamine oleate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ethanolamine oleate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for ETHAMOLIN?
What are the global sales for ETHAMOLIN?
What is Average Wholesale Price for ETHAMOLIN?

Summary for ETHAMOLIN

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	16
Clinical Trials:	1
Patent Applications:	732
What excipients (inactive ingredients) are in ETHAMOLIN?	ETHAMOLIN excipients list
DailyMed Link:	ETHAMOLIN at DailyMed

Drug patent expirations by year for ETHAMOLIN

Recent Clinical Trials for ETHAMOLIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Cancer Institute (NCI)	Phase 1/Phase 2
M.D. Anderson Cancer Center	Phase 1/Phase 2

See all ETHAMOLIN clinical trials

Pharmacology for ETHAMOLIN

Drug Class	Sclerosing Agent
Mechanism of Action	Sclerosing Activity
Physiological Effect	Vascular Sclerosing Activity

US Patents and Regulatory Information for ETHAMOLIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Qol Medcl	ETHAMOLIN	ethanolamine oleate	INJECTABLE;INJECTION	019357-001	Dec 22, 1988		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.